Following the success of our last year’s event held at the beginning of virtual ASCO, we are pleased to announce, our 7th Annual Immuno-Oncology Innovation Forum (#Sachs_IOIF) will take place on the 18th-20th of May 2021.
Due to the pandemic, the #Sachs_IOIF event will be once again hosted in a digital format. This will allow us to further support our community and past attendees, bridging Europe and the US. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system.
The programme for the 7th Annual IOIF will be spread throughout 3 days. Featuring more than 14 hours of keynotes, high-level speeches, panel discussions and spotlight showcases by leading corporates. The event brings together leaders from pharma and biotech as well as cancer research institutes, patient advocacy groups, early and late-stage investors, CMOs and CROs.
We anticipate over 300 delegates and 25+ company presentations by established listed, private and emerging companies. Over half of the attendees are corporate and financial investors, buy-side and sell-side analysts, bankers, legal and business advisors.
As usual, the forum will include an Online Meeting System, which creates a number of networking opportunities for attendees with meeting hosted for a whole week of the conference, from 17th to 21st of May. The system will be open for 24 hours each day to accommodate meeting scheduling for attendees from around the globe. When you will log in to the Online Meeting System for the first time you will be asked to block times that do not suite you to avoid arising conflicts. Sachs support team will be available during conference hours to assist you.
The conference will be held in the Eastern Daylight Time (EDT) zone.
May 18, 2021 @ 9:00 am
May 20, 2021